Meredith Manning

Companies

• SOLENO THERAPEUTICS INCChief Commercial Officer Apr 30, 2024 to now¹
• Adicet Bio, Inc.Chief Commercial Officer Sep 18, 2018 to Feb 28, 2019²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• STSOLENO THERAPEUTICS INC0 shares³May 18, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• May 18, 2026Returned to company 64,507 shares of SOLENO THERAPEUTICS INC³
• Mar 27, 2026Sold 558 shares at $31.72 of SOLENO THERAPEUTICS INC⁴
• Mar 27, 2026Sold 2,100 shares at $31.04 of SOLENO THERAPEUTICS INC⁴
• Mar 27, 2026Sold 4,864 shares at $30.04 of SOLENO THERAPEUTICS INC⁴
• Jan 21, 2026Granted 28,600 shares of SOLENO THERAPEUTICS INC⁵
• Dec 15, 2025Shares withheld for tax 1,922 shares at $49.95 of SOLENO THERAPEUTICS INC⁶
• Mar 27, 2025Sold 37,000 shares at $67.04 of SOLENO THERAPEUTICS INC⁷
• Mar 27, 2025Exercised options 37,000 shares at $46.31 of SOLENO THERAPEUTICS INC⁷
• Mar 27, 2025Sold 34 shares at $72.64 of SOLENO THERAPEUTICS INC⁷
• Mar 27, 2025Sold 225 shares at $71.74 of SOLENO THERAPEUTICS INC⁷
• Mar 27, 2025Sold 155 shares at $70.73 of SOLENO THERAPEUTICS INC⁷
• Mar 27, 2025Sold 1,505 shares at $69.84 of SOLENO THERAPEUTICS INC⁷
• Mar 27, 2025Sold 2,599 shares at $68.79 of SOLENO THERAPEUTICS INC⁷
• Mar 27, 2025Sold 1,976 shares at $67.70 of SOLENO THERAPEUTICS INC⁷
• Mar 27, 2025Sold 1,087 shares at $66.79 of SOLENO THERAPEUTICS INC⁷
• Mar 27, 2025Sold 668 shares at $65.97 of SOLENO THERAPEUTICS INC⁷
• Jan 21, 2025Granted 13,600 shares of SOLENO THERAPEUTICS INC⁸
• Jul 17, 2024Granted 40,000 shares of SOLENO THERAPEUTICS INC⁹